• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Persistence pays off: After 8‑year follow-up, study finds robust and sustained antidepressant response to deep brain stimulation (DBS)

October 14, 2019 by SharpBrains

__________

Long-Term Fol­low-Up Data Shows Deep Brain Stim­u­la­tion Is an Effec­tive Treat­ment for Treat­ment-Resis­tant Depres­sion (Mount Sinai press release):

“A study pub­lished online on Fri­day, Octo­ber 4, in The Amer­i­can Jour­nal of Psy­chi­a­try found that deep brain stim­u­la­tion (DBS) of an area in the brain called the sub­cal­los­al cin­gu­late (SCC) pro­vides a robust anti­de­pres­sant effect that is sus­tained over a long peri­od of time in patients with treat­ment-resis­tant depres­sion—the most severe­ly depressed patients who have not respond­ed to oth­er treatments.

The long-term data pre­sent­ed in this study, con­duct­ed at Emory Uni­ver­si­ty and led by Helen S. May­berg, MD, now Pro­fes­sor of Neu­rol­o­gy, Neu­ro­surgery, Psy­chi­a­try, and Neu­ro­science, and Found­ing Direc­tor of the Nash Fam­i­ly Cen­ter for Advanced Cir­cuit Ther­a­peu­tics at the Icahn School of Med­i­cine at Mount Sinai, val­i­dates ear­li­er work con­duct­ed by the research team and lays the foun­da­tion for addi­tion­al stud­ies to refine and opti­mize DBS for these patients.

Deep brain stim­u­la­tion, cur­rent­ly approved by the U.S. Food and Drug Admin­is­tra­tion to treat essen­tial tremor, Parkinson’s dis­ease, epilep­sy, and obses­sive-com­pul­sive dis­or­der, is a neu­ro­sur­gi­cal pro­ce­dure involv­ing the place­ment of a neu­rostim­u­la­tor (some­times referred to as a “brain pace­mak­er”), which sends high-fre­quen­cy elec­tri­cal impuls­es through implant­ed elec­trodes deep in the brain to spe­cif­ic brain areas respon­si­ble for the symp­toms of each disorder.

Dr. May­berg led the first tri­al of DBS of the sub­cal­los­al cin­gu­late white mat­ter, known as Brod­mann Area 25, for treat­ment-resis­tant depres­sion patients in 2005, demon­strat­ing that it could have clin­i­cal ben­e­fit. Sub­se­quent small open-label tri­als pro­duced sim­i­lar­ly favor­able results, yet despite these encour­ag­ing open-label results, a mul­ti-cen­ter, ran­dom­ized tri­al was halt­ed ear­ly due to a lack of sta­tis­ti­cal­ly sig­nif­i­cant anti­de­pres­sant response at the des­ig­nat­ed, six-month a pri­ori time point.

“Despite the fact that larg­er tri­als were halt­ed ear­ly, what my col­leagues and I were see­ing as we con­tin­ued to fol­low patients from our ini­tial tri­als was that over time, they were get­ting bet­ter and not only that, they were stay­ing bet­ter. So we stayed the course,” says Dr. May­berg. “Over eight years of obser­va­tion, most of our study par­tic­i­pants expe­ri­enced an anti­de­pres­sant response to the deep brain stim­u­la­tion of Area 25 that was robust and sus­tained. Giv­en that patients with treat­ment-resis­tant depres­sion are high­ly sus­cep­ti­ble to recur­rent depres­sive episodes, the abil­i­ty of DBS to sup­port long-term main­te­nance of an anti­de­pres­sant response and pre­ven­tion of relapse is a treat­ment advance that can mean the dif­fer­ence between get­ting on with your life or always look­ing over your shoul­der for your next debil­i­tat­ing depres­sive episode.”

The Study:

Long-Term Out­comes of Sub­cal­los­al Cin­gu­late Deep Brain Stim­u­la­tion for Treat­ment-Resis­tant Depres­sion (Amer­i­can Jour­nal of Psy­chi­a­try). From the abstract:

  • Objec­tive: Deep brain stim­u­la­tion of the sub­cal­los­al cin­gu­late (SCC DBS) has been stud­ied as a poten­tial treat­ment for severe and refrac­to­ry major depres­sive dis­or­der since 2005. The authors used an open-label, long-term fol­low-up design to exam­ine par­tic­i­pants enrolled in a clin­i­cal tri­al of SCC DBS for treat­ment-resis­tant depression.
  • Meth­ods: Long-term out­come data were col­lect­ed for 28 patients (20 with major depres­sive dis­or­der and sev­en with bipo­lar II dis­or­der; one patient in the major depres­sion sub­group was lat­er reclas­si­fied as hav­ing bipo­lar II dis­or­der) receiv­ing SCC DBS for 4–8 years.
  • Results: Response and remis­sion rates were main­tained at 50% and 30%, respec­tive­ly, through years 2–8 of the fol­low-up peri­od. Three-quar­ters of all par­tic­i­pants met the treat­ment-response cri­te­ri­on for more than half of their dura­tion of par­tic­i­pa­tion in the study, with 21% of all patients demon­strat­ing con­tin­u­ous response to treat­ment from the first year onward. Of 28 par­tic­i­pants, 14 com­plet­ed ?8 years of fol­low-up, 11 com­plet­ed 4 years, and three dropped out before 8 years. The pro­ce­dure itself was gen­er­al­ly safe and well tol­er­at­ed, and there were no side effects of acute or chron­ic stim­u­la­tion. The rate of med­ical or sur­gi­cal com­pli­ca­tions was con­sis­tent with the rate observed in stud­ies of DBS for oth­er indi­ca­tions. There were no suicides.
  • Con­clu­sions: In >8 years of obser­va­tion, most par­tic­i­pants expe­ri­enced a robust and sus­tained anti­de­pres­sant response to SCC DBS.

News in Context:

  • Eth­i­cal issues raised around deep brain stim­u­la­tion (DBS) research
  • Clos­ing the Cir­cuit: Helen Mayberg’s research could rev­o­lu­tion­ize depres­sion treatment

Expo Day: Neu­ro­engin­ner­ing, BPI, Arrow­smith Pro­gram & ARPF from Sharp­Brains

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: antidepressant, area-25, brain pacemaker, brain stimulation, DBS, deep-brain-stimulation, depression, Helen-Mayberg, neurosurgical, treatment

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 35,214 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy